Compound 60 has an extremely high affinity to MDM2 (Ki < one nM), potent cellular action, and an excellent oral pharmacokinetic profile. Compound 60 is able to acquiring finish and long-lasting tumor regression in vivo and is also at present in period I clinical trials for cancer procedure. Please see https://andersonq531iou5.wiki-promo.com/user